Stay updated on NVG-111 in ROR1+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.

Latest updates to the NVG-111 in ROR1+ Malignancies Clinical Trial page
- CheckyesterdayChange DetectedA notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. It appears above the study record’s 403 error.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s site revision changes from v3.7.1 to v3.7.2 while the 403 Forbidden error page remains otherwise unchanged.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, indicating restricted access and replacing the previous study content.SummaryDifference19%

- Check57 days agoChange DetectedRevision label in the page footer was updated from v3.6.5 to v3.6.6, indicating a minor platform update. No changes to study content, headings, or links were detected.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision identifier was updated from v3.6.4 to v3.6.5, indicating a small update to the page's metadata or formatting.SummaryDifference0.1%

Stay in the know with updates to NVG-111 in ROR1+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.